Combination of HDAC inhibitors, LAG-3 inhibitors and PD-1 inhibitors or PD-L1 inhibitors for cancer therapy

摘要

The present invention combined with the LAG-3 inhibitor and PD-1 inhibitor or PD-L1 inhibitor for treatment of cancer, the following general formula I(R1, R7 are as described herein.)It relates to the medical use of HDAC inhibitors or their salts or solvates.